Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke

Neuropharmacology

Volumn 63, Issue 8, 2012, Pages 1279-1285

  Moldes, Octavio ^a   Sobrino, Tomás ^a   Blanco, Miguel ^a   Agulla, Jesús ^a   Barral, David ^a   Ramos Cabrer, Pedro ^a   Castillo, José ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Aquaporins; BQ 788; Cerebral ischemia; Clazosentan ; Endothelin 1

Indexed keywords

AQUAPORIN 4; CLAZOSENTAN; ENDOTHELIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION;

ANIMALS; AQUAPORINS; BLOTTING, WESTERN; BRAIN EDEMA; BRAIN ISCHEMIA; DIOXANES; ENDOTHELIN-1; EVOKED POTENTIALS, SOMATOSENSORY; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PIPERIDINES; PYRIDINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; STROKE; SULFONAMIDES; TETRAZOLES;

EID: 84867554768     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.08.019     Document Type: Article

References (37)

1. J. Andresen, N.I. Shafi, and R.M. Bryan Jr. Endothelial influences on cerebrovascular tone J. Appl. Physiol. 100 2006 318 327
2. S.T. Carmichael Rodent models of focal stroke: size, mechanism, and purpose NeuroRx 2 2005 396 409
3. G. Chen, A. Tariq, J. Ai, M. Sabri, H.J. Jeon, E.J. Tang, K. Lakovic, H. Wan, and R.L. Macdonald Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats Brain Res. 1392 2011 132 139
4. J. Chuquet, K. Benchenane, J. Toutain, E.T. MacKenzie, S. Roussel, and O. Touzani Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat Stroke 33 2002 3019 3025
5. A.P. Davenport, and B. Battistini Classification of endothelin receptors and antagonists in clinical development Clin. Sci. (Lond.) 103 Suppl. 48 2002 1S 3S
6. D.A. Dawson, H. Sugano, R.M. McCarron, J.M. Hallenbeck, and M. Spatz Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia Neurochem. Res. 24 1999 1499 1505
7. K. Fassbender, B. Hodapp, S. Rossol, T. Bertsch, J. Schmeck, S. Schütt, M. Fritzinger, P. Horn, P. Vajkoczy, M. Wendel-Wellner, A. Ragoschke, S. Kuehl, J. Brunner, L. Schürer, P. Schmiedeck, and M. Hennerici Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes Stroke 31 2000 2971 2975
8. S. Gasic, O.F. Wagner, H. Vierhapper, P. Nowotny, and W. Waldhäusl Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide J. Cardiovasc. Pharmacol. 19 1992 176 180
9. Y.K. Gupta, S. Briyal, U. Sharma, N.R. Jagannathan, and A. Gulati Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats Life Sci. 77 2005 15 27
10. S. Jesmin, I. Sakuma, H. Togashi, T. Yamaguchi, K. Ueno, M. Yoshioka, Y. Hattori, A. Kitabatake, and T. Miyauchi Altered expression of endothelin and its receptors in the brain of SHR-SP at malignant hypertensive stage J. Cardiovasc. Pharmacol. 44 2004 11 15
11. R.K. Kaundal, T.A. Deshpande, A. Gulati, and S.S. Sharma Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives Drug Discov. Today 17 2012 793 804
12. M. Kavec, O.H. Grohn, M.I. Kettunen, M.J. Silvennoinen, M. Garwood, and R.A. Kauppinen Acute cerebral ischemia in rats studied by Carr-Purcell spin-echo magnetic resonance imaging: assessment of blood oxygenation level-dependent and tissue effects on the transverse relaxation Magn. Reson. Med. 51 2004 1138 1146
13. M.I. Kettunen, O.H. Grohn, J.A. Lukkarinen, P. Vainio, M.J. Silvennoinen, and R.A. Kauppinen Interrelations of T(1) and diffusion of water in acute cerebral ischemia of the rat Magn. Reson. Med. 44 2000 833 839
14. Y. Koyama, and K. Tanaka Decreases in rat brain aquaporin-4 expression following intracerebroventricular administration of an endothelin ET B receptor agonist Neurosci. Lett. 469 2010 343 347
15. M.G. Leonard, S. Briyal, and A. Gulati Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats Brain Res. 1420 2011 48 58
16. T.N. Lin, Y.Y. He, G. Wu, M. Khan, and C.Y. Hsu Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats Stroke 24 1993 117 121
17. A.C. Lo, A.Y. Chen, V.K. Hung, L.P. Yaw, M.K. Fung, M.C. Ho, M.C. Tsang, S.S. Chung, and S.K. Chung Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet J. Cereb. Blood Flow. Metab. 25 2005 998 1011
18. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniectomy in rats Stroke 20 1989 84 91
19. R.L. Macdonald, N.F. Kassell, S. Mayer, D. Ruefenacht, P. Schmiedek, S. Weidauer, A. Frey, S. Roux, A. Pasqualin, and CONSCIOUS-1 Investigators Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial Stroke 39 2008 3015 3021
20. R.L. Macdonald, R.T. Higashida, E. Keller, S.A. Mayer, A. Molyneux, A. Raabe, P. Vajkoczy, I. Wanke, D. Bach, A. Frey, P. Nowbakht, S. Roux, and N. Kassell Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling Stroke 43 2012 1463 1469
21. H.I. Makela, M.I. Kettunen, O.H. Grohn, and R.A. Kauppinen Quantitative T(1rho) and magnetization transfer magnetic resonance imaging of acute cerebral ischemia in the rat J. Cereb. Blood Flow. Metab. 22 2002 547 558
22. Y. Matsuo, Si. Mihara, M. Ninomiya, and M. Fujimoto Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats Stroke 32 2001 2143 2148
23. O. Moldes, T. Sobrino, M. Millán, M. Castellanos, N. Pérez de la Ossa, R. Leira, J. Serena, J. Vivancos, A. Dávalos, and J. Castillo High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA Stroke 39 2008 2006 2010
24. M. Okada, and M. Nishikibe BQ-788, a selective endothelin ET(B) receptor antagonist Cardiovasc. Drug Rev. 20 2002 53 66
25. M. Philip, M. Benatar, M. Fisher, and S.I. Savitz Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials Stroke 40 2009 577 581
26. C. Ribeiro Mde, L. Hirt, J. Bogousslavsky, L. Regli, and J. Badaut Time course of aquaporin expression after transient focal cerebral ischemia in mice J. Neurosci. Res. 83 2006 1231 1240
27. F. Rodríguez-Pascual, O. Busnadiego, D. Lagares, and S. Lamas Role of endothelin in the cardiovascular system Pharmacol. Res. 63 2011 463 472
28. S. Roux, V. Breu, T. Giller, W. Neidhart, H. Ramuz, P. Coassolo, J.P. Clozel, and M. Clozel Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm J. Pharmacol. Exp. Ther. 283 1997 1110 1118
29. M. Sato, and L.J. Noble Involvement of the endothelin receptor subtype A in neuronal pathogenesis after traumatic brain injury Brain Res. 809 1998 39 49
30. T. Schallert, S.M. Fleming, J.L. Leasure, J.L. Tillerson, and S.T. Bland CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury Neuropharmacology 39 2000 777 787
31. S. Taddei, A. Virdis, L. Ghiadoni, I. Sudano, A. Magagna, and A. Salvetti Role of endothelin in the control of peripheral vascular tone in human hypertension Heart Fail. Rev. 6 2001 277 285
32. K. Tanaka, and Y. Koyama Endothelins decrease the expression of aquaporins and plasma membrane water permeability in cultured rat astrocytes J. Neurosci. Res. 89 2011 320 328
33. T. Tatlisumak, R.A. Carano, K. Takano, T.J. Opgenorth, C.H. Sotak, and M. Fisher A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study Stroke 29 1998 850 857
34. E. Thorin, and D.J. Webb Endothelium-derived endothelin-1 Pflugers Arch. 459 2010 951 958
35. S. Wegener, R. Weber, P. Ramos-Cabrer, U. Uhlenkueken, D. Wiedermann, K. Kandal, A. Villringer, and M. Hoehn Subcortical lesions after transient thread occlusion in the rat: T2-weighted magnetic resonance imaging findings without corresponding sensorimotor deficits J. Magn. Reson. Imaging 21 2005 340 346
36. S. Wegener, R. Weber, P. Ramos-Cabrer, U. Uhlenkueken, C. Sprenger, D. Wiedermann, A. Villringer, and M. Hoehn Temporal profile of T2-weighted MRI distinguishes between pannecrosis and selective neuronal death after transient focal cerebral ischemia in the rat J. Cereb. Blood Flow. Metab. 26 2006 38 47
37. R.L. Zhang, C. Zhang, L. Zhang, C. Roberts, M. Lu, A. Kapke, Y. Cui, M. Ninomiya, T. Nagafuji, B. Albala, Z.G. Zhang, and M. Chopp Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke Stroke 39 2008 2830 2836